Filter Results :

Your search for Immune returned 110 reports

Sort by


Oncimmune Ltd (ONC) - Financial and Strategic SWOT Analysis Review

15 May 2017  |  Published by:  GlobalData
SummaryOncimmune Ltd (Oncimmune) is a biotechnology company that discovers and commercializes technologies for the early detection of cancer. The company develops EarlyCDT, a platform technology for detecting early cancer that measures autoantibodies (immuno-biomarkers) in blood that form early in c...

$ 300.00

Read More

Autoimmune Drugs Companies in China

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and ec...

$ 1,800.00

Read More

Autoimmune Drugs Industry Forecasts - China Focus

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China’s Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of ...

$ 1,800.00

Read More

Autoimmune Drugs Markets in China

15 May 2017  |  Published by:  Asia Market Info and Dev Co.
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, con...

$ 4,000.00

Read More

Neurimmune Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 May 2017  |  Published by:  GlobalData
SummaryNeurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The companys pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a foc...

$ 250.00

Read More

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 May 2017  |  Published by:  GlobalData
SummaryNovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and kap...

$ 250.00

Read More

Immune Checkpoints Activators - Competitive Landscape, Technology and Pipeline Analysis, 2017

01 May 2017  |  Published by:  DelveInsight
DelveInsight’s, “Immune Checkpoints Activators - Competitive Landscape, Technology and Pipeline Analysis, 2017”, report provides comprehensive insights about pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the pipeline drugs that ...

$ 2,450.00

Read More

Immune Pharmaceuticals Inc (IMNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

26 Apr 2017  |  Published by:  GlobalData
SummaryImmune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corporation, is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerat...

$ 250.00

Read More

Globeimmune Inc (GBIM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

26 Apr 2017  |  Published by:  GlobalData
SummaryGlobeimmune Inc (Globeimmune) is a biopharmaceutical company that manufactures and distributes therapeutic products for cancer and infectious diseases. It offers products for infectious disease and oncology. The companys oncology products include GI-4000, GI-6207 and GI-6301. Globeimmunes inf...

$ 250.00

Read More

Immune Design Corp (IMDZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

26 Apr 2017  |  Published by:  GlobalData
SummaryImmune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company develops its product candidates through its ZVex and GLAAS discovery platforms. Its product candid...

$ 250.00

Read More

ImmuneXcite Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

26 Apr 2017  |  Published by:  GlobalData
SummaryImmuneXcite Inc (ImmuneXcite) is a biopharmaceutical company that specializes in developing immune-activating biotherapeutics for the treatment of cancer. The company's technological service includes mAbXcite on immunotherapy platform technology. Its solutions are used for the treatment of so...

$ 250.00

Read More

DecImmune Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Apr 2017  |  Published by:  GlobalData
SummaryDecImmune Therapeutics Inc (DecImmune) is a pharmaceutical company that provides monoclonal antibody development solutions. The companys research and development services comprise preclinical proof-of-concept studies, indication studies, intellectual property and partnering services. It also ...

$ 250.00

Read More

The 2018-2023 World Outlook for Autoimmune Disease Diagnostics

24 Apr 2017  |  Published by:  Icon Group International, Inc
This study covers the world outlook for autoimmune disease diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

$ 995.00

Read More

CytImmune Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 Apr 2017  |  Published by:  GlobalData
SummaryCytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company which discovers, develops, and commercializes tumor-targeted therapies for the treatment of cancer. It develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Aurimune selectively binds TNF receptors o...

$ 250.00

Read More

Calimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

20 Apr 2017  |  Published by:  GlobalData
SummaryCalimmune Inc (Calimmune) is a clinical-stage biotechnology company that focuses on the development of novel gene therapies that have the capability to enhance the immune systems of individuals. The company's lead candidate, CAL-1, is being developed to prevent the progression of HIV to AIDS ...

$ 250.00

Read More
Total 110 records.